PROVIDER PROFILE · NPI 1104215888
Katherine MattisonFNP-C
PRESCRIBING · PART D · 2024
Total Rx claims
134
Beneficiaries
—
Total drug cost
$359K
Distinct drugs
8
Brand share
9.0%
Top prescribed drugs
Exemestane29 claims
Anastrozole27 claims
Lenalidomide15 claims
Letrozole14 claims
Imatinib Mesylate14 claims
QUALITY · MIPS · 2024
Final MIPS score
88.9
Quality
72.1
Cost
77.4
Improvement activities
40.0
Promoting interop.
80.0
Payment adjustment
0.58%
Group
CROSS-REFERENCE